Clioquinol independently targets NF-κB and lysosome pathways in human cancer cells

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2087-2092

  Yu, Haijun ^a,b   Lou, Jessica R ^a   Ding, Wei Qun ^a  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Clioquinol; DU 145; Lysosome; NF B

Indexed keywords

AMMONIA; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CLIOQUINOL; DNA; TRANSCRIPTION FACTOR RELA; ZINC CHLORIDE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONCENTRATION RESPONSE; DNA TRANSFECTION; DRUG MECHANISM; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTRACELLULAR SIGNALING; LYSOSOME; MALE; PREMEDICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SINGLE DRUG DOSE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CLIOQUINOL; HUMANS; LEUPEPTINS; LYSOSOMES; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; QUATERNARY AMMONIUM COMPOUNDS; SIGNAL TRANSDUCTION; ZINC;

EID: 77955074869     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nitzan YB, Sekler I, Frederickson CJ, Coulter DA, Balaji RV, Liang SL, Margulis A, Hershfinkel M and Silverman WF: Clioquinol effects on tissue chelatable zinc in mice. J Mol Med 81: 637-644, 2003.
2. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE and Masters CL: Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60: 1685-1691, 2003.
3. Regland B, Lehmann W, Abedini I, Blennow K, Jonsson M, Karlsson I, Sjögren M, Wallin A, Xilinas M and Gottfries CG: Treatment of Alzheimer's disease with clioquinol. Dement Geriatr Cogn Disord 12: 408-414, 2001.
4. Huang R, Wallqvist A and Covell DG: Anticancer metal compounds in NCI's tumor-screening database: putative mode of action. Biochem Pharmacol 69: 1009-1039, 2005. (Pubitemid 40349015)
5. Ding WQ, Liu B, Vaught JL, Yamauchi H and Lind SE: Anticancer activity of the antibiotic clioquinol. Cancer Res 65: 3389-3395, 2005
6. Mao X, Li X, Sprangers R, Wang X, Venugopal A, Wood T, Zhang Y, Kuntz DA, Coe E, Trudel S, Rose D, Batey RA, Kay LE and Schimmer AD: Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma. Leukemia 23: 585-590, 2009.
7. Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP and Dou QP: Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res 67: 1636-1644, 2007.
8. Yu H, Zhou Y, Lind SE and Ding WQ: Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 417: 133-139, 2009.
9. Orlowski RZ and Kuhn DJ: Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 14: 1649-1657, 2008.
10. Guicciardi ME, Leist M and Gores GJ: Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
11. Pommier Y, Sordet O, Antony S, Hayward RL and Kohn KW: Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23: 2934-2949, 2004.
12. Wang CY, Mayo MW and Baldwin AS Jr: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787, 1996.
13. Uchimoto T, Nohara H, Kamehara R, Iwamura M, Watanabe N and Kobayashi Y: Mechanism of apoptosis induced by a lysosomotropic agent, L-leucyl-L-leucine methyl ester. Apoptosis 4: 357-362, 1999.
14. Zdolsek JM: Acridine orange-mediated photodamage to cultured cells. APMIS 101: 127-32, 1993.
15. Ding WQ, Liu B, Vaught JL, Palmiter RD and Lind SE: Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol Cancer Ther 5: 1864-1872, 2006.
16. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
17. Thibodeau MS, Giardina C, Knecht DA, Helble J and Hubbard AK: Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity. Toxicol Sci 80: 34-48, 2004. (Pubitemid 38967394)
18. Lee DH and Goldberg AL: Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8: 397-403, 1998.
19. Ding WX and Yin XM: Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4: 141-50, 2008.
20. Blagosklonny MV: Overcoming limitations of natural anticancer drugs by combining with artificial agents. Trends Pharmacol Sci 26:77-81, 2005. (Pubitemid 40170169)